FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3164184930> ?p ?o ?g. }

• W3164184930 endingPage "816" @default.
• W3164184930 startingPage "815.3" @default.
• W3164184930 abstract "Background: Axial involvement affects 25-70% of psoriatic arthritis (PsA) patients, depending on the criteria used for its definition. Efforts are underway to clarify the similarities and differences between axial-PsA and ankylosing spondylitis (AS). Objectives: We aimed to compare, in a real-world setting, axial-PsA and AS, in terms of demographic, radiologic and clinical (musculoskeletal and extra-articular) characteristics, with a focus on comorbidities. Methods: All AS (New York criteria, n=128) and PsA patients (CASPAR criteria, n=78) with axial involvement who were regularly followed-up in the outpatients’ rheumatology clinics from two tertiary hospitals (December 2018-July 2020) were included. Axial-PsA was defined when both of the following were ever present: inflammatory axial symptoms and radiological findings in X-ray or MRI of the sacroiliac joints or the spine. The following findings were considered: sacroiliitis (unilateral ≥ grade 3 or bilateral ≥ grade 2), corner lesions or squaring in the vertebrae, syndesmophytes (marginal or para-marginal) and facet joints arthritis. Demographic, radiologic and clinical characteristics including comorbidities were compared between AS and axial-PsA. For comorbidities (Major Adverse Cardiovascular Events [MACE: combined coronary disease and cerebrovascular accidents], hypertension, diabetes mellitus, dyslipidemia, depression, osteoporosis, and malignancies), adjustments were made for relevant confounders as follows: MACE were adjusted for: age, gender, smoking, hypertension, dyslipidemia, disease duration, DM and non-steroidal anti-inflammatory drugs [NSAIDs] use; depression for: age, gender and disease duration; malignancy for: age, gender, disease duration; hypertension for: age, sex, BMI, NSAIDs use, smoking for; DM: age, sex, BMI, glucocorticoids treatment; osteoporosis for: age, sex, glucocorticoids treatment. Statistical significance is considered for p-values less than 0.05 and 0.1 in univariate and multivariate analyses, respectively. Results: AS patients were younger (p=0.05) and were diagnosed at a younger age (p=0.002), more frequently of male gender (p=0.04), had lower BMI (p=0.006) and they were more frequently HLA-B27-positive (p=0.006). In AS patients, peripheral arthritis, dactylitis and nail involvement were less common (p=0.001 for all), in contrast to eye (p=0.001) and bowel involvement (p=0.004). Frequency of radiologic abnormalities in the spine was similar between the two groups while sacroiliitis was more often bilateral in AS and unilateral in axial-PsA (p<0.001 for both) Comorbidities, including MACE, were comparable between AS and axial-PsA, apart from depression which was more frequent in axial-PsA (Table 1. next page). Table 1. Comorbidities. Comparison between axial-PsA and AS. OR: odds ratio, MACE: Major cardiovascular events. * adjustments are reported in the text Comorbidities axial-PsA (n=79 ) AS (n=129 ) Crude OR (95%CI ) Adjusted OR (95%CI ) p-value MACE* n (%) 4 (5.1) 6 (4.6) 0.91 (0.25-3.34) 1.73 (0.32-9.34) 0.526 Dyslipidemia n (%) 37 (46.8) 45 (34.9) 0.61 (0.34-1.07) NA 0.108 Hypertension* n (%) 27 (34.2) 24 (18.6) 0.44 (0.23-0.83) 1.11 (0.38-3.21) 0.843 Diabetes mellitus* n (%) 12 (15.2) 10 (7.7) 0.47 (0.19-1.14) 1.65 (0.43-6.29) 0.463 Depression* n (%) 19 (24.1) 16 (12.4) 0.44 (0.21-0.93) 0.48 (0.22-1.07) 0.07 Osteoporosis* n (%) 3 (3.8) 10 (7.7) 2.13 (0.57-7.98) 2.40 (0.56-10.18) 0.235 Malignancies* n (%) 3 (3.8) 3 (2.3) 0.60 (0.12-3.06) 0.87 (0.16-4.70) 0.870 Conclusion: AS and axial-PsA have certain clinical and radiologic differences. Comorbidities were comparable, while depression was more common in axial-PsA. Disclosure of Interests: George E. Fragoulis: None declared, Maria Pappa: None declared, Gerasimos Evangelatos: None declared, Alexios Iliopoulos: None declared, Petros Sfikakis Grant/research support from: AbbVie, Pfizer, MSD, Roche, UCB, GSK, Novartis, Maria Tektonidou Grant/research support from: AbbVie, GSK, Genesis, MSD, Novartis, Pfizer, UCB." @default.
• W3164184930 created "2021-06-07" @default.
• W3164184930 creator A5028791605 @default.
• W3164184930 creator A5058747002 @default.
• W3164184930 creator A5059064100 @default.
• W3164184930 creator A5069190715 @default.
• W3164184930 creator A5075515457 @default.
• W3164184930 creator A5079914575 @default.
• W3164184930 date "2021-05-19" @default.
• W3164184930 modified "2023-09-25" @default.
• W3164184930 title "POS1073 AXIAL PSORIATIC ARTHRITIS AND ANKYLOSING SPONDYLITIS. SAME OR DIFFERENT? A REAL-WORLD STUDY WITH EMPHASIS ON COMORBIDITIES" @default.
• W3164184930 doi "https://doi.org/10.1136/annrheumdis-2021-eular.2129" @default.
• W3164184930 hasPublicationYear "2021" @default.
• W3164184930 type Work @default.
• W3164184930 sameAs 3164184930 @default.
• W3164184930 citedByCount "1" @default.
• W3164184930 countsByYear W31641849302022 @default.
• W3164184930 crossrefType "journal-article" @default.
• W3164184930 hasAuthorship W3164184930A5028791605 @default.
• W3164184930 hasAuthorship W3164184930A5058747002 @default.
• W3164184930 hasAuthorship W3164184930A5059064100 @default.
• W3164184930 hasAuthorship W3164184930A5069190715 @default.
• W3164184930 hasAuthorship W3164184930A5075515457 @default.
• W3164184930 hasAuthorship W3164184930A5079914575 @default.
• W3164184930 hasBestOaLocation W31641849301 @default.
• W3164184930 hasConcept C126322002 @default.
• W3164184930 hasConcept C139719470 @default.
• W3164184930 hasConcept C141071460 @default.
• W3164184930 hasConcept C162324750 @default.
• W3164184930 hasConcept C1862650 @default.
• W3164184930 hasConcept C198451711 @default.
• W3164184930 hasConcept C2776260265 @default.
• W3164184930 hasConcept C2776541429 @default.
• W3164184930 hasConcept C2776867660 @default.
• W3164184930 hasConcept C2777402515 @default.
• W3164184930 hasConcept C2777453003 @default.
• W3164184930 hasConcept C2778096610 @default.
• W3164184930 hasConcept C2778579456 @default.
• W3164184930 hasConcept C2779134260 @default.
• W3164184930 hasConcept C2779650986 @default.
• W3164184930 hasConcept C2780415856 @default.
• W3164184930 hasConcept C71924100 @default.
• W3164184930 hasConceptScore W3164184930C126322002 @default.
• W3164184930 hasConceptScore W3164184930C139719470 @default.
• W3164184930 hasConceptScore W3164184930C141071460 @default.
• W3164184930 hasConceptScore W3164184930C162324750 @default.
• W3164184930 hasConceptScore W3164184930C1862650 @default.
• W3164184930 hasConceptScore W3164184930C198451711 @default.
• W3164184930 hasConceptScore W3164184930C2776260265 @default.
• W3164184930 hasConceptScore W3164184930C2776541429 @default.
• W3164184930 hasConceptScore W3164184930C2776867660 @default.
• W3164184930 hasConceptScore W3164184930C2777402515 @default.
• W3164184930 hasConceptScore W3164184930C2777453003 @default.
• W3164184930 hasConceptScore W3164184930C2778096610 @default.
• W3164184930 hasConceptScore W3164184930C2778579456 @default.
• W3164184930 hasConceptScore W3164184930C2779134260 @default.
• W3164184930 hasConceptScore W3164184930C2779650986 @default.
• W3164184930 hasConceptScore W3164184930C2780415856 @default.
• W3164184930 hasConceptScore W3164184930C71924100 @default.
• W3164184930 hasIssue "Suppl 1" @default.
• W3164184930 hasLocation W31641849301 @default.
• W3164184930 hasOpenAccess W3164184930 @default.
• W3164184930 hasPrimaryLocation W31641849301 @default.
• W3164184930 hasRelatedWork W2003412506 @default.
• W3164184930 hasRelatedWork W2056519404 @default.
• W3164184930 hasRelatedWork W2318158934 @default.
• W3164184930 hasRelatedWork W2319295728 @default.
• W3164184930 hasRelatedWork W2320356529 @default.
• W3164184930 hasRelatedWork W2325038909 @default.
• W3164184930 hasRelatedWork W2334903757 @default.
• W3164184930 hasRelatedWork W2950768534 @default.
• W3164184930 hasRelatedWork W3174072327 @default.
• W3164184930 hasRelatedWork W4214620322 @default.
• W3164184930 hasVolume "80" @default.
• W3164184930 isParatext "false" @default.
• W3164184930 isRetracted "false" @default.
• W3164184930 magId "3164184930" @default.
• W3164184930 workType "article" @default.